Law Expert Says High Court Likely to Favor Prometheus Test Patent

Drug Industry Daily
While the U.S. Supreme Court appears unconvinced after oral arguments on Prometheus Laboratories’ thiopurine metabolites test patent, one legal expert predicts the high court will uphold an appeals court decision in favor of Prometheus.

To View This Article:


Subscribe To Drug Industry Daily